Your source for the latest medtech news from AdvaMed® and our members.
Scott Whitaker, President and CEO of AdvaMed®, the Medtech Association, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply…
AdvaMed® President and CEO Scott Whitaker released the following statement regarding the 14th Ministerial-level Trade Policy Forum held in New Delhi, India:
The investments being made in our domestic semiconductor chip manufacturing base under the CHIPS and Science Act are critical for the medtech industry and the millions of patients who rely…
Less than six months after earning FDA clearance for its PrecisionTAVI product, DASI Simulations Founder and Chief Technology Officer Dr. Lakshmi (Prasad) Dasi announced today that the Centers for Medicare & Medicaid…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
Nanowear, a leader in healthcare-at-home remote diagnostics, announced that its nanotechnology-enabled wearable and software platform, SimpleSenseTM, has received FDA 510(k) clearance for a novel AI-enabled Software-as-a-Medical Device (SaMD). As the…
In a new op-ed in RealClear Health, AdvaMed® President and CEO Scott Whitaker called on the Biden Administration to ensure the medtech industry is considered as it implements policies to…
Today, diabetes was front and center during a Senate HELP Committee hearing, prompting AdvaMed® President and CEO Scott Whitaker to release the following statement on the ways life-saving medical technology…
Today, AdvaMedDx® submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx® is a division of AdvaMed® representing companies that develop in…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Today, AdvaMed® President and CEO Scott Whitaker released the following statement upon House passage of The Prematurity Research Expansion and Education for Mothers who deliver Infants Early (PREEMIE) Reauthorization Act: